Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells

[1]  N. Zarghami,et al.  The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action , 2022, Applied Biochemistry and Biotechnology.

[2]  P. Vineis,et al.  Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking , 2022, European Journal of Epidemiology.

[3]  N. Zarghami,et al.  Design and fabrication of a dual-drug loaded nano-platform for synergistic anticancer and cytotoxicity effects on the expression of leptin in lung cancer treatment , 2022, Journal of Drug Delivery Science and Technology.

[4]  A. Mahfuz,et al.  Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review. , 2022, ACS applied bio materials.

[5]  N. Zarghami,et al.  Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation , 2022, Asian Pacific journal of cancer prevention : APJCP.

[6]  N. Zarghami,et al.  An update on mode of action of metformin in modulation of meta-inflammation and inflammaging , 2022, Pharmacological Reports.

[7]  H. Car,et al.  Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment , 2021, International journal of nanomedicine.

[8]  N. Zarghami,et al.  New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles. , 2021, Current Cancer Drug Targets.

[9]  A. Azadi,et al.  Optimization, Physicochemical Characterization, and Antimicrobial Activity of a Novel Simvastatin Nano-niosomal Gel against E. coli and S. aureus. , 2020, Chemistry and physics of lipids.

[10]  Xiao-qin Wu,et al.  Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  M. Mino‐Kenudson,et al.  Molecular Pathology of Primary Non-small Cell Lung Cancer. , 2020, Archives of medical research.

[12]  S. Yaghmaei,et al.  Niosomal delivery of simvastatin to MDA-MB-231 cancer cells , 2020, Drug development and industrial pharmacy.

[13]  I. Akbarzadeh,et al.  Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: An in-vitro investigation , 2020 .

[14]  Yeonho Choi,et al.  Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes. , 2020, ACS nano.

[15]  Duckshin Park,et al.  Indoor Air Pollution, Related Human Diseases, and Recent Trends in the Control and Improvement of Indoor Air Quality , 2020, International journal of environmental research and public health.

[16]  A. Thor,et al.  Metformin Activity against Breast Cancer: Mechanistic Differences by Molecular Subtype and Metabolic Conditions , 2020 .

[17]  Haleh Bakhshandeh,et al.  Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37 , 2019, International journal of nanomedicine.

[18]  I. Akbarzadeh,et al.  Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. , 2019, International journal of pharmaceutics.

[19]  M. Torkzadeh-Mahani,et al.  In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents , 2019, Research in pharmaceutical sciences.

[20]  Leila Faramarzi,et al.  Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells , 2018, Iranian journal of basic medical sciences.

[21]  N. Venkatesh,et al.  Smart niosomes of temozolomide for enhancement of brain targeting , 2018, Nanobiomedicine.

[22]  M. Mirzaei,et al.  Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer , 2018, DARU Journal of Pharmaceutical Sciences.

[23]  Jiajun Chen,et al.  Effect of artemisinin on proliferation and apoptosis-related protein expression in vivo and in vitro , 2018, Saudi journal of biological sciences.

[24]  M. Jabbari,et al.  Effects of nano-encapsulated curcumin-chrysin on telomerase, MMPs and TIMPs gene expression in mouse B16F10 melanoma tumour model , 2018, Artificial cells, nanomedicine, and biotechnology.

[25]  Kazem Nejati-Koshki,et al.  Recent Advances in Cell Electrospining of Natural and Synthetic Nanofibers for Regenerative Medicine , 2018, Drug Research.

[26]  R. Salehi,et al.  Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells , 2018, Chemical biology & drug design.

[27]  J. Ruda-Kucerova,et al.  Anticancer Activity of Artemisinin and its Derivatives. , 2017, Anticancer research.

[28]  N. Zarghami,et al.  The inhibitory effects of nano-encapsulated metformin on growth and hTERT expression in breast cancer cells , 2017 .

[29]  A. Akbarzadeh,et al.  The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells. , 2017, Anti-cancer agents in medicinal chemistry.

[30]  G. Rajabzadeh,et al.  α-Tocopherol-loaded niosome prepared by heating method and its release behavior. , 2017, Food chemistry.

[31]  H. T. Aiyelabegan,et al.  Synthesis and Characterization of Chrysin-loaded PCL-PEG-PCL nanoparticle and its effect on breast cancer cell line. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  F. Mohammadian,et al.  Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line , 2016, Iranian journal of cancer prevention.

[33]  N. Zarghami,et al.  An Update on Phytochemicals in Molecular Target Therapy of Cancer: Potential Inhibitory Effect on Telomerase Activity. , 2016, Current medicinal chemistry.

[34]  Mengyao Qin,et al.  Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. , 2016, Colloids and surfaces. B, Biointerfaces.

[35]  G. Fetih,et al.  Performance of Meloxicam Niosomal Gel Formulations for Transdermal Drug Delivery , 2016 .

[36]  A. Elkordy,et al.  In vitro characterisation of Span 65 niosomal formulations containing proteins. , 2015, Current drug delivery.

[37]  Mohamed A. Shaker,et al.  Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. , 2015, International journal of pharmaceutics.

[38]  R. Muzzalupo,et al.  Niosomal drug delivery for transdermal targeting: recent advances , 2015 .

[39]  M. Ansari,et al.  Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats , 2015, Drug delivery.

[40]  Joe Y. Chang,et al.  ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer , 2015, American journal of clinical oncology.

[41]  K. Mahadik,et al.  Potentiating antimicrobial efficacy of propolis through niosomal-based system for administration , 2014, Integrative medicine research.

[42]  Chuanbin Wu,et al.  Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[43]  Saeid Moghassemi,et al.  Nano-niosomes as nanoscale drug delivery systems: an illustrated review. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[44]  S Furlanetto,et al.  Development and characterization of functionalized niosomes for brain targeting of dynorphin-B. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  H. Abdelkader,et al.  Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug , 2014, Journal of Pharmaceutical Investigation.

[46]  R. Alany,et al.  Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations , 2014, Drug delivery.

[47]  S. Harikumar,et al.  Design and development of cefdinir niosomes for oral delivery , 2013, Journal of pharmacy & bioallied sciences.

[48]  J. Roh,et al.  Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer. , 2012, Oncology letters.

[49]  Raida Al-Kassas,et al.  Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. , 2012, International journal of pharmaceutics.

[50]  N. Mishra,et al.  Effect of Surfactants on the Characteristics of Fluconazole Niosomes for Enhanced Cutaneous Delivery , 2011, Artificial cells, blood substitutes, and immobilization biotechnology.

[51]  S. K. Mehta,et al.  Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. , 2011, Colloids and surfaces. B, Biointerfaces.

[52]  R. Alany,et al.  Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.

[53]  A. Pardakhty,et al.  Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery , 2010, Journal of microencapsulation.

[54]  M. Carafa,et al.  Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[55]  J. Manosroi,et al.  Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. , 2010, International journal of pharmaceutics.

[56]  J. Menéndez,et al.  The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells , 2009, Cell cycle.

[57]  F. Ahmad,et al.  Nonionic Surfactant Vesicles as a Carrier for Transdermal Delivery of Frusemide , 2008 .

[58]  W. Pitt,et al.  The role of cavitation in liposome formation. , 2007, Biophysical journal.

[59]  A. Pardakhty,et al.  Caffeine-Loaded Niosomes: Characterization and in Vitro Release Studies , 2007, Drug delivery.

[60]  C. Jain,et al.  Niosomal system for delivery of rifampicin to lymphatics , 2006 .

[61]  D. Christensen,et al.  The role of cavitation in acoustically activated drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[62]  B. Nasseri.  Effect of cholesterol and temperature on the elastic properties of niosomal membranes. , 2005, International journal of pharmaceutics.

[63]  S. Lim,et al.  The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol , 2005, Journal of liposome research.

[64]  A. Pardakhty,et al.  Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery , 2003, Drug delivery.

[65]  K. Li,et al.  Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.

[66]  J. Minna,et al.  Focus on lung cancer. , 2002, Cancer cell.

[67]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[68]  I. Wistuba,et al.  Precursors to Pulmonary Neoplasia , 1998, Advances in anatomic pathology.

[69]  A. Florence,et al.  Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85) , 1994 .

[70]  A. Florence,et al.  The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.

[71]  Khalid M El-Say,et al.  Maximizing the Therapeutic Efficacy of Imatinib Mesylate-Loaded Niosomes on Human Colon Adenocarcinoma Using Box-Behnken Design. , 2017, Journal of pharmaceutical sciences.

[72]  O. El-Gazayerly,et al.  NIOSOME-ENCAPSULATED CLOMIPRAMINE FOR TRANSDERMAL CONTROLLED DELIVERY , 2014 .

[73]  Marwa Helmy Abedullahh.  PREPARATION AND IN-VITRO EVALUATION OF DICLOFENAC SODIUM NIOSOMAL FORMULATIONS , 2013 .

[74]  A. Akbarzadeh,et al.  Inhibitory effects of β-cyclodextrin-helenalin complexes on H-TERT gene expression in the T47D breast cancer cell line - results of real time quantitative PCR. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[75]  P. Prabhakara,et al.  Development and Characterization of Non-Ionic Surfactant Vesicles(Niosomes) for Oral delivery of Lornoxicam , 2012 .

[76]  A. Pardakhty,et al.  Pharmacokinetic study of niosome-loaded insulin in diabetic rats , 2011, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences.

[77]  W. Travis.  Pathology & Genetics Tumours of the lung, Pleura, Thymus and Heart , 2004 .

[78]  S. Lesieur,et al.  Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles : evidence of membrane impermeability to octyl glucoside , 1996 .

[79]  C. Cable.  An examination of the effect of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles , 1990 .